Empagliflozin induced ketoacidosis in a patient presenting with new onset type 2 diabetes mellitus due to indolent pancreas cancer.

Empagliflozin induced ketoacidosis in a patient presenting with new onset type 2 diabetes mellitus due to indolent pancreas cancer.
Endokrynol Pol. 2020 Mar 10;:
Authors: Sezer H, Yazıcı D, Deyneli O, Meriçöz Ç, Esin A, Alper E
Abstract
Not required for Clinical Vignette.
PMID: 32154575 [PubMed - as supplied by publisher]

Source: Endokrynologia Polska - March 9, 2020 Category: Endocrinology Authors: Sezer H, Yazıcı D, Deyneli O, Meriçöz Ç, Esin A, Alper E Tags: Endokrynol Pol Source Type: research